Nonetheless, the augmented expression of HO-1 in tumor tissues may have detrimental effects as it provides the selective advantage for tumor cells to overcome the increased oxidative stress during tumorigenesis and during treatment [2]. The gene discussed is HMOX1; the disease is neoplasm.